NDC properties for NDC 9 0378-0217
NDC item 00378021701
| NDC 9 | 0378-0217 |
|---|---|
| NDC 10 | 0378-0217-01 |
| NDC Item | 00378021701 |
| packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0217-01) |
| ANDA | ANDA070259 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 385950 |
| Imprint code | MYLAN;217;250 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-03-31 |
| Marketing effective time low | 2013-01-18 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
NDC item 68084055611
| NDC 9 | 68084-556 |
|---|---|
| NDC 10 | 68084-556-11 |
| NDC Item | 68084055611 |
| ANDA | ANDA070259 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 157905 |
| Imprint code | MYLAN;217;250 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-05-31 |
| Marketing effective time low | 2012-02-13 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
NDC item 68084055621
| NDC 9 | 68084-556 |
|---|---|
| NDC 10 | 68084-556-21 |
| NDC Item | 68084055621 |
| packaging | 3 BLISTER PACK in 1 CARTON (68084-556-21) / 10 TABLET in 1 BLISTER PACK (68084-556-11) |
| ANDA | ANDA070259 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 157905 |
| Imprint code | MYLAN;217;250 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-05-31 |
| Marketing effective time low | 2012-02-13 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |